# Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant

> **NCT00571662** · PHASE2 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 76 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Acute Lymphocytic Leukemia
- Chronic Myelogenous Leukemia
- Chronic Lymphocytic Leukemia
- Myelodysplastic Syndromes
- Multiple Myeloma
- Non-Hodgkins Lymphoma
- Hodgkins Disease
- Peripheral T-cell Lymphoma

## Interventions

- **DRUG:** Pentostatin
- **RADIATION:** Total-body irradiation (TBI)
- **DRUG:** Cyclosporine A (CsA)
- **DRUG:** Mycophenolate Mofetil (MMF)
- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT00571662
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12-08
- **Primary completion:** 2008-12-30
- **Final completion:** 2008-12-30
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2023-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00571662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00571662, "Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT00571662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*